Hisako sells MYL 46.19: Mylan Applauds Court's Ruling Dismissing Teva's Suit Against FDA on Copaxone®
PITTSBURGH, May 15, 2014 /PRNewswire/ -- Mylan Inc. (NASDAQ:MYL) today commented on the ruling by the U.S. District Court for the District of Columbia against Teva in their suit against the U.S. Food and Drug Administration (FDA), which denied Teva's ... ...
50 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home